Coromandel International Ltd. Share Price

Overview

Coromandel International Ltd. share price is currently ₹1,738.08, down by - ₹16.17 (0.92%) from its previous closing price of ₹1,754.25. The share price has declined -8.92% over the past month and declined -20.97% over the past year. The stock's 52-week low and high are ₹1,623.38 and ₹2,483.54, respectively. Coromandel International Ltd. has a market capitalisation of ₹ 50,160.00 Cr. The share price was last updated on 16 Oct 2026, 03:29 PM IST.

Coromandel International Ltd.
Coromandel International Ltd.
COROMANDEL
 ₹0.00
- ₹16.17
0.92%
Chemicals
 ₹0.00(%)1D

Updated: 16 Oct 2026, 03:29:46 pm IST

Market Data

Open Price

 ₹1,748.35

Prev. Close

 ₹1,754.25
 ₹1,712.41

Day Low

 ₹1,755.17

Day High

 ₹1,623.38

52 Week Low

 ₹2,483.54

52 Week High

ChemicalsFertilizers
CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

27.98

Sector PE

28.49

PB Ratio

4.09

Sector PB

4.09

EPS

62.11

Dividend Yield

0.58

Today's Volume

245.153 K

5 Day Avg. Volume

195.740 K

PEG Ratio

-5.12

Market Cap.

₹ 50,160.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 200% at ₹2/Share
16-Jul-202616-Jul-2026
DividendsInterim Dividend of 900% at ₹9/Share
04-Feb-202604-Feb-2026
DividendsSpecial Dividend of 300% at ₹3/Share
17-Jul-202517-Jul-2025
DividendsFinal Dividend of 600% at ₹6/Share
17-Jul-202517-Jul-2025

Mutual Fund Ownership

Mutual Fund Holder
Aug 26
Shares held
Sep 26
Shares held
HDFC Mid Cap Fund - Regular Plan - Growth61.48 Lac
68.78 Lac
(11.87%)
Kotak Mid Cap Fund - Regular Plan - Growth57.29 Lac
57.29 Lac
no change
Kotak Large & Mid Cap Fund - Growth32.00 Lac
32.00 Lac
no change
DSP Midcap Fund - Regular Plan - Growth25.42 Lac
25.42 Lac
no change
Axis Midcap Fund - Regular Plan - Growth20.19 Lac
18.55 Lac
(8.09%)

About Coromandel International Ltd. 👋

Coromandel International Limited is engaged in the manufacturing and trading of farm inputs consisting of fertilizers, crop protection, specialty nutrients and organic compost. The Company's segments include Nutrient and other allied businesses, and Crop Protection. The Company's fertilizers products include GroShakti Plus, Grosmart, Paramfos, Gromor 15-15-15-09, Godavari Ultra DAP, Gromor / Godavari DAP, Gromor MOP, Gromor Urea, and others. Its speciality nutrients products include Acumist Calcium, AcuMist Zinc, Sulphamax, and others. Its crop protection products consist of insecticides, fungicides, herbicides, plant growth regulators and bio-products. It offers organic fertilizers derived from natural sources like city waste (organic portion only), sugarcane molasses and its by-products, oil cakes and gypsum. The Company operates a network of over 900 rural retail outlets across India.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Vibhu Jain

Vibhu Jain

14 Oct • 9:34 PM · SEBI-Registered Analyst

Coromandel International analysis on different parameters

COROMANDEL
Quality :- Coromandel International Ltd continues to demonstrate solid operational fundamentals, with its quality metrics maintaining a favourable standing. The company’s return on equity (ROE) stands at 15.9%, indicating a reasonable level of profitability relative to shareholder equity. However, recent quarterly results reveal a contraction in profit before tax and net profit, signalling challenges in sustaining earnings momentum. The operating cash flow for the year has also shown a subdued level, which may impact the company’s ability to fund growth initiatives or manage working capital efficiently. Valuation :- The stock is currently perceived as very expensive based on valuation metrics. Trading at a price-to-book value of 4.1, it commands a premium relative to its sector peers and historical averages. This elevated valuation reflects market expectations for future growth, but it also introduces a degree of risk should earnings fail to meet these anticipations. The premium pricing, combined with recent profit declines, has contributed to a reassessment of the company’s market standing. Financial :- The company reported a 21.85% decline in profit before tax excluding other income for the quarter ending June 2026, alongside a 24.6% drop in net profit. These figures suggest pressures on the core business, possibly due to input cost inflation, competitive dynamics, or sector-specific challenges. Year-to-date returns have been negative, with the stock posting a decline of 23.52%, and a one-year return of -20.24%, underscoring the cautious sentiment among investors. Technical :-The technical indicators for Coromandel International Ltd have shifted towards a bearish stance. The stock’s price performance over recent months has been under pressure, with a one-month decline of 9.85% and a three-month drop exceeding 16%. This downward trend reflects investor caution and may be influenced by broader sectoral headwinds or company-specific developments.

See More
SHUBINVESTS I SEBI RA

SHUBINVESTS I SEBI RA

30 Sep • 9:20 AM · SEBI-Registered Analyst

When Guaranteed Returns Meet Reality.....

A farmer cannot guarantee the weather. A business cannot guarantee profits. So when an investment platform promises assured 10–15% tax-free returns, the first question should not be “How much will I earn?” “Where will the return actually come from?” SEBI’s September 2026 final order in the Growpital matter provides a powerful lesson. SEBI found that the platform had raised around ₹193 crore from more than 5,200 investors through schemes presented around agricultural operations. One striking example was the claimed ₹62 crore revenue from jeera grown on a 75-acre plot. The order examined agricultural yield and mandi-price data and found a huge gap between the claimed revenue and what the land could reasonably produce. • Is the return assured or market-linked? • Can the underlying business generate the claimed cash flows? • Are the assets and operations independently verifiable? • Who controls the money? • What regulatory framework applies? • Does the legal structure match the economic reality? And there is an important distinction: a genuine agricultural business can create value, but that does not automatically make every investment scheme built around agriculture legitimate. Interestingly, listed businesses can provide a completely different way to study the agricultural ecosystem. Coromandel International

COROMANDEL
operates across fertilisers, crop protection, specialty nutrients, bio-products and agri-retail. In FY26, it reported ₹31,827 crore of consolidated turnover and continued expanding its agricultural-input network. That does not make it a recommendation or guarantee future returns. It simply illustrates the difference between studying a disclosed listed business and believing an unsupported return promise. Never evaluate an investment only by promised returns; verify the underlying economics, cash flows, assets, regulation, ownership and risks first.

See More
Dhwani Patel

Dhwani Patel

19 Sep • 2:02 PM · SEBI-Registered Analyst

Coromandel International: Weekly Chart at a Decision Point

COROMANDEL
closed around ₹1,999.5 on the weekly chart, up 3.65%. The long-term trend remains constructive: the stock has risen substantially from its earlier base and continues to trade near the upper end of its multi-year range. The current weekly structure, however, is in a decision zone. Price is sitting around the Ichimoku cloud, with the cloud roughly between ₹1,981 and ₹1,999.5. The Tenkan-sen is near ₹2,010, while the Kijun-sen is near ₹1,952. This means the stock has improving short-term momentum, but it has not yet cleared all of its overhead resistance. A sustained move above ₹2,010 would be the first positive confirmation. The stronger breakout level is around ₹2,100, near the recent swing resistance and forward cloud boundary. Above that, the stock could resume its broader uptrend. On the downside, ₹1,981 is the first support, followed by ₹1,952. A weekly close below ₹1,952 would make the setup meaningfully weaker. Coromandel’s position in fertilizers, crop protection and agricultural inputs gives the business a strong structural theme, but the chart is currently better described as a consolidation near support than a confirmed breakout. The key is whether price can reclaim ₹2,010 and then challenge ₹2,100. Disclaimer - No Position

See More
Pavan Rawat

Pavan Rawat

26 Aug • 5:35 PM · SEBI-Registered Analyst

ORIENTAL HOTELS MERGER COULD BOOST INDIAN HOTELS' EPS

ORIENTHOT
The proposed merger of Oriental Hotels Ltd. with Indian Hotels Company Ltd. is expected to be earnings-per-share accretive for Indian Hotels. Indian Hotels currently owns a 37.1% stake in Oriental Hotels. Under the share-swap arrangement, shareholders of Oriental Hotels will receive 25 Indian Hotels shares for every 117 shares held. As part of the transaction, Indian Hotels will issue approximately 23.2 million new shares. The company expects to complete the merger by FY28, with April 1 designated as the appointed date from which the financial accounts, assets and liabilities of the two companies will be treated as combined. Indian Hotels has indicated that its EBITDA margin could rise to more than 30% following the merger, compared with 26.8% in FY26. The company highlighted the potential margin improvement in its investor presentation dated August 24. IHCL also plans to capitalize on expansion opportunities across Oriental Hotels' existing portfolio. The 149-key Taj Fisherman’s Cove in Chennai offers scope for adding villas and expanding banqueting facilities. Similar expansion opportunities have been identified at the 63-key Gateway Madurai. To drive growth in total revenue per available room (TREVPAR), IHCL plans to renovate the 220-key Taj Coromandel in Chennai and the 96-key Vivanta property in Mangalore. Taj Coromandel is also slated for upgrades to its food and beverage outlets and Chambers’ Club.

See More
Pankaj pawar

Pankaj pawar

24 Aug • 11:54 AM · SEBI-Registered Analyst

AUROPHARMA
, USFDA Inspection & Specialty Fertiliser

**

AUROPHARMA
:** USFDA completed a routine inspection at its U.S. subsidiary **Lannett Company LLC**, with **four procedural observations**. The company is required to submit its compliance response to the USFDA within the stipulated timeline. **Stock Commentary:** **Neutral to Mildly Negative;** four observations create a near-term regulatory overhang, but the impact will depend on the company's response and subsequent USFDA assessment. No immediate business disruption has been indicated. **Deepak Fertilisers, Coromandel & SML:** Companies are increasingly focusing on **specialty nutrients and fertilisers**, where nutrient-use efficiency can be significantly higher than conventional urea. Urea efficiency is estimated at around **30–40%**, compared with **80–85% for specialty fertilisers**, creating scope for wider adoption. ** !DEEPAKFERT– Stock Commentary:** **Positive;** increasing focus on specialty nutrients can support demand for value-added fertiliser products and improve the company's long-term growth and margin profile. **Coromandel International – Stock Commentary:** **Positive;** rising adoption of high-efficiency specialty fertilisers can strengthen the company's product mix and support growth in value-added agricultural inputs. **SML – Stock Commentary:** **Positive;** the shift toward efficient specialty nutrients provides an opportunity to expand its presence in higher-value fertiliser segments and improve long-term revenue visibility.

See More
Sarathi Research

Sarathi Research

24 Aug • 10:05 AM · SEBI-Registered Analyst

Oriental Hotels in Focus After Merger With Indian Hotels

ORIENTHOT
Oriental Hotels shares jumped more than 5% today after the company announced a merger with Indian Hotels Company, the operator of the Taj brand. The proposed merger is aimed at simplifying the group structure and unlocking value from Oriental Hotels’ portfolio. Oriental Hotels owns and operates several prominent hospitality assets, including Taj Coromandel in Chennai. The transaction is subject to statutory approvals and other required clearances. Investors are watching the deal because it could improve operational efficiency and create greater value from the hotel portfolio. The announcement has triggered fresh buying interest in Oriental Hotels shares. The stock is therefore among the notable hospitality counters in focus today.

See More

Frequently Asked Questions

What is the share price of Coromandel International Ltd.?

What is the market cap of Coromandel International Ltd.?

Should I buy Coromandel International Ltd. stock now?

What is the 52 week high and low of Coromandel International Ltd.?

Is the Coromandel International Ltd. stock good to buy?

Is Coromandel International Ltd. a good buy for the long term?

Is Coromandel International Ltd. overvalued or undervalued?

What is the PE and PB ratio of Coromandel International Ltd.?

Start Now